Zobrazeno 51 - 60
of 104
pro vyhledávání: '"Katy K. Tsai"'
Autor:
Mandar A. Aras, Nelson B. Schiller, Katy K. Tsai, Qizhi Fang, Roman Zingarelli, Adil Daud, Dwight Bibby
Publikováno v:
Journal of Clinical Oncology. 38:e24060-e24060
e24060 Background: Immune checkpoint inhibitors (ICI) effect durable responses in cancer patients (pts). Myocarditis is rare but fatigue is commonly reported, and whether ICI-induced fatigue is due to subclinical cardiac toxicity is unknown. We hypot
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 17(7)
Clear cell basal cell carcinoma (BCC) is an unusual variant of BCC. Its pathogenesis, prognosis, and optimal management remain poorly described due to its rarity. This report presents a 51-year-old man with a history of excised BCC and cutaneous squa
Publikováno v:
Cancer. 124(13)
The rate of advances in uveal melanoma has not kept pace with the rate of advances in cutaneous melanoma. Many patients lack access to or knowledge of specialty centers, and integrated multidisciplinary care between ophthalmology, radiation oncology,
Publikováno v:
Clinical pharmacology and therapeutics. 102(5)
Tyrosine kinase inhibitors (TKIs) are a targeted class of cancer therapies effective against a range of malignancies and their use is growing significantly each year. Many men taking TKIs desire children, yet very little is known about the potential
Autor:
James Lee, Lawrence Chen, Miguel Hernandez Pampaloni, Matthew F. Krummel, Michael Rosenblum, Kimberly Loo, Kelly M. Mahuron, Lauren S. Levine, Adil Daud, Katy K. Tsai, Mariela L. Pauli, Priscila Munoz Sandoval, Adi Nosrati, Alain Algazi, Michael Alvarado, Jimmy Hwang, Jacqueline Liu
Publikováno v:
JCI insight, vol 2, iss 14
Background Programmed death 1 (PD-1) inhibition activates partially exhausted cytotoxic T lymphocytes (peCTLs) and induces tumor regression. We previously showed that the peCTL fraction predicts response to anti-PD-1 monotherapy. Here, we sought to c
Autor:
Barbara Grimes, Adil Daud, Alain Algazi, Simone M. Goldinger, Katy K. Tsai, Adi Nosrati, Thi Dan Linh Nguyen-Kim, Omid Hamid, Kimberly Loo, Reinhard Dummer, Mitchell P. Levesque, Paul C. Tumeh
Publikováno v:
British journal of cancer, vol 116, iss 9
British Journal of Cancer
British Journal of Cancer
Background: Anti-PD-1 therapy has shown significant clinical activity in advanced melanoma. We developed and validated a clinical prediction scale for response to anti- PD-1 monotherapy. Methods: A total of 315 patients with advanced melanoma treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d683abcf1a5f1faf44bf15c07b9b302
https://escholarship.org/uc/item/8w50t9tw
https://escholarship.org/uc/item/8w50t9tw
Publikováno v:
Journal of Urology. 197
Implementation Science Workshop: Primary Care-Based Multidisciplinary Readmission Prevention Program
Autor:
Genevieve G.R. Embree, Brooke McGuirt, Michael Pignone, Katy K. Tsai, Shana Ratner, Darren A. DeWalt, Betsy Bryant Shilliday, Jamie Cavanaugh, Robin Roche, Christine D Jones, Thomas Miller
Publikováno v:
Journal of General Internal Medicine
To define comorbidities including chronic obstructive pulmonary disease or asthma, heart failure, diabetes, hypertension, coronary artery disease, and depression, we required the condition to be listed either on the index hospitalization discharge su
Autor:
Dwight Bibby, Adil Daud, Katy K. Tsai, Qizhi Fang, Nelson B. Schiller, Mandar A. Aras, Lauren M Cuevas
Publikováno v:
Journal of Clinical Oncology. 37:e14157-e14157
e14157 Background: Immune checkpoint inhibitors (ICI) demonstrate activity and long-term benefit in melanoma and other cancers. While certain immune-related toxicities have been well described, cardiac toxicities remain poorly characterized. We sough